Quantification of total homocysteine in human plasma or serum by liquid chromatography-tandem mass spectrometry for use in clinical research

Significance of the Topic

Homocysteine is a key intermediate in the methionine cycle and its total concentration in plasma or serum serves as an important biomarker for cardiovascular disease risk, cognitive decline and other metabolic disorders. Accurate and precise measurement of total homocysteine supports clinical research into nutritional influences, genetic factors and disease progression.

Objectives and Overview

The study aimed to develop and evaluate a simple, high-throughput liquid chromatography tandem mass spectrometry method for quantification of total homocysteine in human plasma or serum. The protocol reduces protein-bound and dimerized forms into free homocysteine, applies rapid sample processing and achieves robust detection using a Thermo Scientific TSQ Quantis triple quadrupole mass spectrometer.

Methodology and Instrumentation

Sample Preparation

• Calibrators and controls covering 0.794 to 6.86 ng/mL
• Reduction step to convert all homocysteine species into the free form
• Protein precipitation followed by centrifugation and transfer of supernatant

Chromatography

• Isocratic elution at 0.55 mL per minute
• Total runtime 1.2 minutes with 5 µL injection volume
• Analytical column and mobile phase provided by the kit manufacturer

Mass Spectrometry

• Heated electrospray ionization in positive mode
• Selected reaction monitoring with two transitions per compound for quantification and confirmation
• d8 Homocystine internal standard detected as d4 homocysteine

Used Instrumentation

• Thermo Scientific Transcend II liquid chromatography system
• Thermo Scientific TSQ Quantis triple quadrupole mass spectrometer
• Thermo Scientific TraceFinder 4.1 software for data acquisition and processing

Results and Discussion

The method demonstrated excellent linearity with correlation coefficients above 0.999 across the calibration range. No significant carryover was observed in blank injections following the highest calibrator. Accuracy bias for quality controls ranged between -2.2 and -1.7 percent. Intra-assay precision remained below 2.1 percent coefficient of variation, and inter-assay precision did not exceed 2.0 percent. These metrics confirm the method’s robustness, sensitivity and reproducibility for clinical research applications.

Benefits and Practical Applications

• Minimal sample volume (50 µL plasma or serum)
• Rapid sample preparation and chromatographic runtime
• High throughput suitable for large studies
• Reliable quantification to support nutritional metabolomics and disease biomarker research

Future Trends and Opportunities

Advances may include integration of homocysteine analysis with broader metabolite panels, automated workflows for higher sample throughput and coupling to multi-omics platforms. Miniaturized and point-of-care MS technologies could further expand clinical utility. Ongoing developments in reagent kits and software will streamline assay deployment and data interpretation.

Conclusions

A fast, sensitive and reproducible LC MS MS method for total homocysteine in human plasma or serum was established on a Thermo Scientific Transcend II and TSQ Quantis system. The protocol meets research laboratory needs for accuracy, precision and throughput and offers a valuable tool for clinical and nutritional metabolomics studies.